FluoGuide submits clinical trial application for head and neck cancer treatment: Biotech company moves forward with phase 2 trial for precision cancer surgery #News
PharmaTimes Media Ltd
Pharmaceutical Manufacturing
Leatherhead, Surrey 12,663 followers
Kickstarting healthcare conversations.
About us
Kickstarting healthcare conversations. PharmaTimes Magazine is the leading pharmaceutical magazine for senior decision makers in the pharma and healthcare industries. It is recognised for its wide-ranging coverage of the key developments facing this fast-paced sector, and its analytical, independent content. PharmaTimes Magazine has a dedicated staff of writers and editors who have many years' experience in writing and editing copy for pharma and healthcare readers in national newspapers, magazines and online. PharmaTimes Magazine readers range from pharmaceutical executives, to healthcare professionals (chief pharmacists, medicines management, academic health science networks and NHS commissioners), to government ministers. Available in print and digital versions, on Newsstand and Google Play. PharmaTimes Competitions provide business partners and sponsors with unique access to senior decision makers, in order to gain real insight into the business challenges faced by pharma customers. This allows partners and sponsors the opportunity to build relationships and formulate service offerings around customer needs.
- Website
-
http://www.pharmatimes.com
External link for PharmaTimes Media Ltd
- Industry
- Pharmaceutical Manufacturing
- Company size
- 11-50 employees
- Headquarters
- Leatherhead, Surrey
- Type
- Privately Held
- Founded
- 1988
- Specialties
- PharmaTimes Magazine specialises in Independent reporting for the independent thinker, Daily independent pharmaceutical e-news, Recognition of individual excellence through pharmaceutical competitions, and Pharmaceutical jobs
Locations
-
Primary
Mansard House
Church Road, Little Bookham
Leatherhead, Surrey RH202LG, GB
Employees at PharmaTimes Media Ltd
Updates
-
Scottish patients first in UK to access new lung cancer treatment: Scottish Medicines Consortium recommends pembrolizumab for high-risk NSCLC patients #News
Scottish patients first in UK to access new lung cancer treatment - PharmaTimes
https://pharmatimes.com
-
IRLAB’s new drug shows promise in treating apathy in Parkinson’s patients: Phase 1 trial of IRL757 demonstrates good absorption and safety profile #Uncategorized #News
IRLAB’s new drug shows promise in treating apathy in Parkinson’s patients - PharmaTimes
https://pharmatimes.com
-
ERLEADA shows 23% survival benefit over enzalutamide in prostate cancer study: Largest real-world study demonstrates significant survival advantage #News
ERLEADA shows 23% survival benefit over enzalutamide in prostate cancer study - PharmaTimes
https://pharmatimes.com
-
Insilico Medicine reports positive results for idiopathic pulmonary fibrosis therapy: ISM001-055 shows promise in improving lung function among patients #News
Insilico Medicine reports positive results for idiopathic pulmonary fibrosis therapy - PharmaTimes
-
AlzeCure’s abstract on ACD856’s effects to be presented at Alzheimer’s conference: Preclinical data on NeuroRestore therapy to be showcased at CTAD in Madrid #News
AlzeCure’s abstract on ACD856’s effects to be presented at Alzheimer’s conference - PharmaTimes
https://pharmatimes.com
-
Great company: ICON celebrates 2024 ‘company of the year’ win #ThoughtLeadership
Great company - PharmaTimes
https://pharmatimes.com
-
European Commission approves yuvanci for pulmonary arterial hypertension treatment: Janssen-Cilag therapy becomes the first single tablet combination therapy for PAH in europe #News
European Commission approves yuvanci for pulmonary arterial hypertension treatment - PharmaTimes
https://pharmatimes.com
-
Dr Alex Dickinson: Sphere Fluidics has appointed Dr Alex Dickinson to its Board of Directors #Appointments
Dr Alex Dickinson - PharmaTimes
https://pharmatimes.com
-
Lots in translation: Harnessing vital patient data for precision in clinical trials #ThoughtLeadership
Lots in translation - PharmaTimes
https://pharmatimes.com